Pharma Journalist -

AveXis, a Novartis company, announced the US Food and Drug Administration (FDA) has approved Zolgensma (onasemnogene abeparvovec-xioi) for the treatment of pediatric patients less than…
Read More...

GlaxoSmithKline plc announced that the National Medical Products Administration (NMPA) has approved Shingrix for the prevention of shingles (herpes zoster) in adults aged 50 years or…
Read More...

ProBioGen AG announced the closing of a services and license agreement with Abcuro, Inc. Pursuing a new generation of immune modulatory bio-therapeutics, Abcuro has developed a new…
Read More...

Santhera Pharmaceuticals announces that it has entered into an exclusive license agreement with Chiesi Farmaceutici, an international research-focused healthcare group (Chiesi Group),…
Read More...

Trovagene, Inc., a clinical-stage oncology therapeutics company, taking a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of…
Read More...

CALECIM Cosmeceuticals (CALECIM), a wholly owned subsidiary of biotechnology company CellResearch Corporation (CRC), has formed a major partnership with A. Menarini Asia-Pacific…
Read More...

Aequus Pharmaceuticals Inc. is pleased to announce an agreement for the Zepto Precision Pulse Capsulotomy device with The Kensington Eye Institute, a world renowned clinic and leader in…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the supplemental New Drug…
Read More...

SMi reports: With only two weeks until SMi’s 3rd Annual Pharmaceutical Microbiology West Coast taking place in San Diego on June 5th & 6th 2019, the event has sold out! Rapid…
Read More...

Halozyme Therapeutics announced that argenx has selected a second target under the collaboration and license agreement the companies announced in February 2019. The second target…
Read More...